Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mr A Clover 04/03/2017 Mr M Clover 25/03/2021 Mr H Sommer 25/03/2021 22 December 2025 The principal activity of the company is that of an investment company. 10652245 2025-03-31 10652245 bus:Director1 2025-03-31 10652245 bus:Director2 2025-03-31 10652245 bus:Director3 2025-03-31 10652245 2024-03-31 10652245 core:CurrentFinancialInstruments 2025-03-31 10652245 core:CurrentFinancialInstruments 2024-03-31 10652245 core:ShareCapital 2025-03-31 10652245 core:ShareCapital 2024-03-31 10652245 core:RetainedEarningsAccumulatedLosses 2025-03-31 10652245 core:RetainedEarningsAccumulatedLosses 2024-03-31 10652245 core:OtherPropertyPlantEquipment 2024-03-31 10652245 core:OtherPropertyPlantEquipment 2025-03-31 10652245 core:CostValuation 2024-03-31 10652245 core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 10652245 core:CostValuation 2025-03-31 10652245 core:RemainingRelatedParties core:CurrentFinancialInstruments 2025-03-31 10652245 core:RemainingRelatedParties core:CurrentFinancialInstruments 2024-03-31 10652245 2024-04-01 2025-03-31 10652245 bus:FilletedAccounts 2024-04-01 2025-03-31 10652245 bus:SmallEntities 2024-04-01 2025-03-31 10652245 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10652245 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10652245 bus:Director1 2024-04-01 2025-03-31 10652245 bus:Director2 2024-04-01 2025-03-31 10652245 bus:Director3 2024-04-01 2025-03-31 10652245 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-04-01 2025-03-31 10652245 2023-04-01 2024-03-31 10652245 core:Associate1 2024-04-01 2025-03-31 10652245 core:Associate1 1 2024-04-01 2025-03-31 10652245 core:Associate1 1 2023-04-01 2024-03-31 10652245 core:CurrentFinancialInstruments 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure decimalUnit

Company No: 10652245 (England and Wales)

AH CLOVER LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

AH CLOVER LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

AH CLOVER LIMITED

COMPANY INFORMATION

For the financial year ended 31 March 2025
AH CLOVER LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 March 2025
DIRECTORS Mr A Clover
Mr M Clover
Mr H Sommer
REGISTERED OFFICE 22 Chancery Lane
London
WC2A 1LS
United Kingdom
COMPANY NUMBER 10652245 (England and Wales)
AH CLOVER LIMITED

BALANCE SHEET

As at 31 March 2025
AH CLOVER LIMITED

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Investments 4 2,519,258 2,520,396
2,519,258 2,520,396
Current assets
Cash at bank and in hand 9,167 11,310
9,167 11,310
Creditors: amounts falling due within one year 5 ( 2,649,055) ( 2,643,055)
Net current liabilities (2,639,888) (2,631,745)
Total assets less current liabilities (120,630) (111,349)
Net liabilities ( 120,630) ( 111,349)
Capital and reserves
Called-up share capital 1 1
Profit and loss account ( 120,631 ) ( 111,350 )
Total shareholder's deficit ( 120,630) ( 111,349)

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of AH Clover Limited (registered number: 10652245) were approved and authorised for issue by the Board of Directors on 22 December 2025. They were signed on its behalf by:

Mr H Sommer
Director
AH CLOVER LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
AH CLOVER LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

AH Clover Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 22 Chancery Lane, London, WC2A 1LS, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Fixed asset investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment. Investments in associates, being entities over which the company has significant influence and that is neither a subsidiary nor a joint venture, are measured at cost less any accumulated impairment losses.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Ordinary share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the company during the year, including directors 1 1

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2024 1,909 1,909
At 31 March 2025 1,909 1,909
Accumulated depreciation
At 01 April 2024 1,909 1,909
At 31 March 2025 1,909 1,909
Net book value
At 31 March 2025 0 0
At 31 March 2024 0 0

4. Fixed asset investments

Listed investments Investments in associates Total
£ £ £
Cost or valuation before impairment
At 01 April 2024 5,799 2,514,597 2,520,396
Movement in fair value ( 1,138) 0 ( 1,138)
At 31 March 2025 4,661 2,514,597 2,519,258
Carrying value at 31 March 2025 4,661 2,514,597 2,519,258
Carrying value at 31 March 2024 5,799 2,514,597 2,520,396

Investments in shares

Name of entity Registered office Principal activity Class of
shares
Ownership
31.03.2025
Ownership
31.03.2024
ONE.IO Group Limited 6th Floor Kings House, 9 - 10 Haymarket, London, England, SW1Y 4BP Holding company Ordinary 33.33% 33.33%

5. Creditors: amounts falling due within one year

2025 2024
£ £
Amounts owed to related parties (note 6) 97,710 97,710
Other creditors 2,551,345 2,545,345
2,649,055 2,643,055

Other creditors include an amount due to Jandy (JH) Limited, a company under common control, of £2,541,145 (2024: £2,541,145). The amount is unsecured, interest free and repayable on demand.

6. Related party transactions

Transactions with the entity's directors

2025 2024
£ £
Director's current account 97,710 97,710

At the balance sheet date the amount owed to A Clover was £97,710 (2024 - £97,710). The amount is unsecured,
interest free and repayable on demand.